Literature DB >> 26637848

Innovative Therapeutic Strategies in the Treatment of Meningioma.

Gerardo Caruso1, Samer K Elbabaa2, Pablo Gonzalez-Lopez3, Valeria Barresi4, Marcello Passalacqua5, Maria Caffo5.   

Abstract

Few medical options are available for progressive/recurrent and atypical/anaplastic meningiomas. New developments in chemotherapeutic options for meningiomas have been explored over the past decade. We review the more recent literature to recognize studies investigating recent medical and chemotherapeutic agents that have been experienced or are currently being tested for meningiomas. Combination therapies affecting multiple molecular targets are currently opening up and present significant promise as adjuvant therapeutic options. However, there is an evident need for new molecular studies in order to better understand the biology of meningiomas and, thus, to identify new and more specific therapeutic targets. Copyright
© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Meningioma; nanomedicine; review; surgery; targeted therapies; treatment

Mesh:

Substances:

Year:  2015        PMID: 26637848

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

Review 1.  Meningiomas and Proteomics: Focus on New Potential Biomarkers and Molecular Pathways.

Authors:  Rosaria Viola Abbritti; Francesca Polito; Maria Cucinotta; Claudio Lo Giudice; Maria Caffo; Chiara Tomasello; Antonino Germanò; Mohammed Aguennouz
Journal:  Cancer Genomics Proteomics       Date:  2016 09-10       Impact factor: 4.069

2.  Apatinib in recurrent anaplastic meningioma: a retrospective case series and systematic literature review.

Authors:  Yong Wang; Wenke Li; Nianliang Jing; Xiangji Meng; Shizhen Zhou; Yufang Zhu; Jun Xu; Rongjie Tao
Journal:  Cancer Biol Ther       Date:  2020-03-25       Impact factor: 4.742

3.  Antitumor activity of gemcitabine against high-grade meningioma in vitro and in vivo.

Authors:  Hiroyuki Takeda; Masashi Okada; Kenta Kuramoto; Shuhei Suzuki; Hirotsugu Sakaki; Tomomi Sanomachi; Shizuka Seino; Takashi Yoshioka; Hirofumi Hirano; Kazunori Arita; Chifumi Kitanaka
Journal:  Oncotarget       Date:  2017-06-29

4.  Hypofractionated high-energy proton-beam irradiation is an alternative treatment for WHO grade I meningiomas.

Authors:  Pavlos Vlachogiannis; Olafur Gudjonsson; Anders Montelius; Erik Grusell; Ulf Isacsson; Kristina Nilsson; Erik Blomquist
Journal:  Acta Neurochir (Wien)       Date:  2017-10-24       Impact factor: 2.216

5.  Modulation of Dkk-3 and claudin-5 as new therapeutic strategy in the treatment of meningiomas.

Authors:  Maria Caffo; Emanuela Esposito; Valeria Barresi; Gerardo Caruso; Salvatore M Cardali; Mariagrazia Rinaldi; Raffaella Mallamace; Michela Campolo; Giovanna Casili; Alfredo Conti; Antonino Germanò; Salvatore Cuzzocrea; Letteria Minutoli
Journal:  Oncotarget       Date:  2017-08-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.